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Abstract                                                      
  Determination of platinum (Pt) derived from cisplatin in tissues was         
performed by electrospray ionization mass spectrometry (ESI-MS) using      
silver (Ag) as the internal standard.   Pt and Ag reacted with             
diethyldithiocarbamate (DDC), and were extracted using  
isoamylalcohol and acidified with oxalic acid.    The compounds were  
termed Pt(DDC)3+ and Ag(DDC)2+, based on their m/z values exhibiting  
the highest peaks at m/z 639 and m/z 405, respectively.   The limit of  
detection was 30 pg and the quantitation range was from 100 to 10000  
pg using 5 mg tissue.   The present method allowed the determination  
of Pt in wet-ashed tissue in 10 minutes. 
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1. Introduction 
  Platinum (Pt) compounds such as cisplatin, cis-diamminedichloro platinum(II),        
and carboplatin are well-known antitumor agents [1].   Diethyldithiocarbamate  
(DDC, (C2H5)2NCSS) is known to form a complex with Pt replacing other  
ligands previously bonded [2,3].   We observed that the Pt-DDC complex   
could be extracted thoroughly with isoamylalcohol (IAA) at pH 3 – 7.   The  
extraction of the complex with IAA results in not only its concentration but also  
in the elimination of most substances contained in biological materials, enabling  
injection of the sample in the direct mode without staining the inside of the  
capillary in electrospray ionization (ESI)-mass spectrometry (MS).    In  
addition, we found that acidification of the Pt-DDC complex, i.e., the formation  
of a ternary complex, enhanced the signal of Pt(DDC)3+ in ESI-MS.  MS is a  
powerful technique for the determination of Pt. Mass dependent determinations  
of Pt in several biological samples were performed using inductively coupled  
plasma (ICP) MS [4,5,6].   However, ICP-MS, requires rather large sample  
sizes that are not applicable to small animal tissue as well as human biopsy  
tissue.    Previous studies have shown that the absolute amounts of Pt  
required at the limit of detection were 10 ng in 0.1 ml human plasma [4], 60  
pg in 300 mg fish liver [5] and 1 ng in 1 ml human plasma [6], respectively.  
In the present ESI-MS study, the limit of detection was 30 pg of Pt in 5 mg  
tissue where this amount enabled the measurement several times, since only  
1 μl out of 10 μl IAA dissolving 30 pg Pt was injected in each measurement.  
Furthermore, monoatomic isobars such as Hg and Os could potentially  
interfere with the determination of Pt by ICP-MS in addition to  
interference by polyatomic isobars such as WO, YbO, HfO, LuO and TaO [5]. 
Among these elements, interference from Hg and W should be noted since  
concentrations of Hg and W in tissues are occasionally elevated due to strong  
binding to thiol proteins following absorption.   The present ESI-MS  
study confirmed that 10 ng of Hg, W (and Hf) did not interfere with the  
determination of Pt.   Ag was used as the internal standard (IS) in the  
quantitation, since interfering signals from biological substances are not 
observed in the Ag(DDC)2+ signal and the signal intensity of Ag per atom 
is comparable to that of Pt under the present treatment.  
2. Materials and Methods 
2.1. Chemicals   
   HNO3, Pt4+, Ag+ and other metal ion standard solutions of atomic  
absorption grade, cisplatin and other chemicals of analytical grade were  
obtained from Wako Pure Chemical Ltd., Japan.    IAA suitable for  
nucleic acid purification was obtained from Sigma-Aldrich Co., USA.    
Pt4+ and Ag+ standard solutions at 1 μg/μl, respectively, were used as  
stock solutions.   Cisplatin was dissolved in 1 M HCl at 0.5 μg Pt2+/μl  
and was used as a stock solution.   Pure water, having a specific  
resistance of 18 MΩcm, was used.   All glassware or plastics were  
soaked in conc. or 0.3 M HNO3, respectively, overnight and rinsed at  
least 10 times with pure water.  
2.2. Materials  
Ethical approval was obrained for the removal of tissue from one patient  
and three reference subjects.   A 68-year-old male with malignant  
lymphoma received an accidental overdose of 165 mg cisplatin/24 h,  
administered as an intravenous infusion for almost 3 days, until the  
patient noted the onset of hearing loss.   The total cisplatin dose  
received was 426 mg and the patient’s body weight was 56.3 kg. 
Intravenous hydration and administration of diuretics were initiated  
immediately.   The patient received 13 sessions of plasmapheresis,  
7 sessions of hemodialysis and 3 sessions of bilirubin adsorption  
totally.   Death of the patient occurred on day 44, following the  
accidental overdose of cisplatin.   A forensic autopsy was  
performed and cerebrum, cerebellum, thymus, heart, adrenal, testis,  
pancreas, lung, spleen, kidney and liver were collected and Pt levels were 
examined.  Corresponding tissues from a healthy 60-year-old male 
and two healthy females (32 years and 64 years old) subjected to  
forensic autopsy, were obtained and subsequently used as the  
reference material for validation of the assay.  
 
2.3. Wet-ashing  
   Tissues from reference subjects were spiked with cisplatin (either 0,  
6, 20, 100, 200 or 2000 pg Pt2+) and Ag+ (either 0 or 1000 pg)/mg  
wet weight.   Patient tissues were spiked with Ag+ at 1000 pg/mg  
wet weight.   Five mg of wet tissue was mixed with 5 μl of conc.  
HNO3 and wet-ashed at 85℃ for 8 h [7].  The final volume was  
adjusted to 10 μl.   The amounts of samples and reagents in  
wet-ashing could be increased proportionally.    The wet-ashed  
solutions could be used for one month at room temperature. 
2.4. Sample preparation for examining recoveries and matrix effects 
   Pt2+ (at 200 and 2000 pg/mg) and Ag+ (at 1000 pg/mg) were spiked  
to reference tissues before and after the wet-ashing to examine the  
recoveries of Pt and Ag in wet-ashing.   Similarly, Pt2+ (at 100 and  
1000 pg/μl) and Ag+ (at 500 pg/μl) were spiked to either wet-ashed  
solutions of the reference tissues or 7M NaNO3 aqueous solution to  
examine the matrix effect of wet-ashed tissue solution on ionization.    
2.5 Sample preparation for calibration and quality control 
   Calibration standard solutions and quality control solutions were  
prepared by spiking Pt2+ at either 0, 3, 10, 50, 100 or 1000 pg /μl to  
wet-ashed solutions of reference tissues containing Ag+ at 500 pg/μl. 
  
2.6. Analytical procedure 
   The pH of wet-ashed tissue solution (10 μl) was adjusted to 3 - 7  
with either 10 M NaOH or 7 M HNO3.   (Small differences of aqueous  
volumes due to pH adjustment did not influence greatly on the volume of  
IAA added in the subsequent step, since the solubility of IAA in the pH  
adjusted tissue solution was quite low.)  1 μl of 1 M DDC was then  
added to the solution.   After 3 min, 10 μl of IAA was added and  
mixed for 30 sec, and separated by centrifugation.   The IAA layer was  
mixed with 10 μl of 1 M oxalic acid for 10 sec and centrifuged.    A  
1-μl aliquot of IAA layer was subjected to ESI-MS.   The peaks of  
both Pt(DDC)3+ and Ag(DDC)2+ appeared 1 min after the injection.  
 
2.7. ESI-MS operating conditions 
   ESI-MS was performed by using a TSQ 7000 LC/MS/MS quadrupole  
mass spectrometer (Thermo Quest, Japan) in the positive ion mode.   One  
μl of the IAA layer was injected manually in the direct mode.   The mobile  
phase consisted of methanol at a flow rate of 200 μl/min.   The spray  
voltage was set at +4.5 kV, and the fused silica capillary temperature was  
set at 280 ℃ since the peaks of both Pt(DDC)3+ and Ag(DDC)2+  
increased following an increase in temperature from170 to 280 ℃.    
Nitrogen was used as the sheath gas (68 p.s.i.) and the auxiliary gas  
(8 units) to assist with nebulization.   The electron multiplier was set  
at 1.3 kV and the scan time, 1.8 sec between m/z 100 and 1000.     
The quantitation of Pt was conducted by simultaneously detecting  
two molecular ions at m/z 639 for Pt(DDC)3+ and m/z 405 for  
Ag(DDC)2+ as IS in selected ion monitoring (SIM) mode.  Eight  
different types of ions can be monitored simultaneously by TSQ  
7000. 
 
3. Results and discussion 
3.1 ESI-MS 
  Figure 1 shows an ESI-MS of 1 μl of IAA containing 1 ng Pt and 1 ng Ag.  
A cluster of peaks at around m/z 405 were the signal of Ag(DDC)2+; those  
at around m/z 491, the signal of Pt(DDC)2+; and those at around m/z 639, the 
signal of Pt(DDC)3+, respectively (Fig.1(a)).  The highest peak at m/z 639  
corresponds to 195Pt(12C51H1014N32S2)3 and other peaks, to the mixture of  
isotopes with natural abundances as Pt of 192Pt(0.8%), 194Pt(32.9%),  
195Pt(33.8%), 196Pt(25.3%), 198Pt(7.2%), S of 32S(95.0%), 33S(0.8%),  
34S(4.2%) and C of 12C(98.9%), 13C(1.1%), as shown in the expanded  
spectrum (Fig. 1(b)).   Ag consists of two isotopes 107Ag(51.8%) and  
109Ag(48.2%).  Molecular ions showed clusters of peaks with their  
isotopes, and the shapes of the clusters proved useful for identification 
purposes.   Figure 2(a) shows the mass spectrum of 10 pg Pt and 50 pg  
Ag.    However, in the negative ion mode, Pt and Ag did not show any  
peaks corresponding to their compounds under the same treatment as that  
in the positive ion mode.   Figure 3 shows the mass spectra of flow  
injections monitored at m/z 639 for Pt(DDC)3+.  
 
3.2 Difference between cisplatin and Pt4+  
  The height of two peaks at m/z 639 and m/z 491, in addition to the  
peak-height ratio between them, 5 : 1, derived from cisplatin, were the  
same as those derived from Pt4+, respectively, in either 7M NaNO3  
aqueous solution or wet-ashed tissue solution where the pH was  
adjusted between 3 - 7, indicating that cisplatin reacted similarly as Pt4+  
in approximately 7M NO3− solution.   When the pH of the solution  
was below 3, the peak at m/z 639 relatively decreased, and the peak at  
m/z 491 increased in both cisplatin and Pt4+.   When the concentration  
of Cl− is decreased, the hydrolysis of cisplatin occurs [8].  The  
majority of metal ions are oxidized to ions with higher valence states in  
NO3− solution, and these ions also favor higher valence states when the pH  
of the solution is elevated.  These properties may explain why a tiny  
amount of cisplatin (Pt2+) behaved similarly to Pt4+ in wet-ashed tissue  
solution, i.e., approximately 7M NaNO3 solution.    
 
3.3 Effects of solvents and acids 
  The ionization efficiencies of both Pt(DDC)3+ and Ag(DDC)2+  
were relatively low without acid treatment following IAA extraction  
from 7M NaNO3 solution.   The ionization efficiencies of Pt(DDC)3+  
after several acid treatments were compared using IAA as an extractor,  
and were expressed as a % assuming the efficiency of 1 M oxalic  
acid to be100 %.   The efficiencies were100 % by either 0.2 – 2 M  
oxalic acid or 1 M HCl, 60 % by either 1 M citric acid or 0.5 M  
H2SO4 and 40 % by 1 M HNO3, respectively.   The ionization  
efficiencies of Ag(DDC)2+ after acid treatment were 100 % by 1 M  
oxalic acid and 50 % by 1 M HCl, respectively.   Using 1 M oxalic  
acid as an acidifier, the extraction efficiencies of several solvents were  
compared.    The extraction efficiencies of IAA, cyclohexanol,  
octanol and chloroform were 100, 100,100 and 20 %, respectively, for Pt  
and those of IAA, cyclohexanol and octanol were100, 70 and 60 %,  
respectively, for Ag.    Since IAA and 1 M oxalic acid gave the best  
result for Pt and Ag, IAA and 1 M oxalic acid were used throughout the  
measurements, and hereafter IAA was defined as the IAA acidified by  
1 M oxalic acid. 
 
3.4 Recoveries and effects of matrix 
  The peak areas of Pt(DDC)3+ and Ag(DDC)2+ in IAA, extracted  
from two types of wet-ashed solutions, were compared.   The solution  
where Pt2+ and Ag+ were spiked to tissues before wet-ashing and the 
solution where Pt2+ and Ag+ were spiked after wet-ashing were used. 
They were the same within a difference of 5 % in all eleven kinds of  
tissues spiked with 200 and 2000 pg Pt2+/mg and 1000 pg Ag+/mg wet  
weight.   These high recoveries may be due to stable and non-volatile  
properties of Pt2+ and Ag+.    Owing to these high recoveries, the  
calibration standard and the quality control can be prepared by  
dissolving Pt2+ and Ag+ to wet-ashed solutions of reference tissues.  
   To examine the effects of wet-ashed tissue solution on ionization,  
the peaks of Pt(DDC)3+ and Ag(DDC)2+ in IAA extracted from  
wet-ashed tissue solutions were compared with those extracted from the 
7M NaNO3 aqueous solution.   Since both peaks of Pt(DDC)3+ and  
Ag(DDC)2+ in IAA extracted from wet-ashed tissue solutions showed  
30 % lower than those extracted from the 7M NaNO3 aqueous solution,  
calibration standards as well as quality controls should be prepared  
using wet-ashed tissue solutions.  In ESI-MS, the possibility of  
ionization suppression of analytes by a matrix must be considered  
especially for methods involving direct injection and LC methods with a  
short run time [9,10,11].   The suppression is only 30 % in the present  
direct injection analysis, even though the procedure is reasonably simple  
and requires only 10 min in total for the extraction and detection of  
analytes.    We confirmed that, in addition to common salts and amino  
acids, transition metals such as Fe, Zn, Mn, Mo and Cr were also eliminated  
mostly in the extraction of analytes with IAA from wet-ashed tissue  
solution at pH 7.   When the IAA was mixed with 1 M oxalic acid to  
form ternary complexes of analytes, most impurities still contained in  
the IAA were removed using 1 M oxalic acid.   In the present study,  
matrix effects were also relieved since the peak of analyte and that of IS  
were observed at the same time. 
   Both signals of Pt(DDC)3+ and Ag(DDC)2+ in IAA extracted from  
wet-ashed tissue solution remained constant for 3 h, and decreased to 
approximately 80 % after 24 h.   However, both signals in IAA  
extracted from 7M NaNO3 aqueous solution remained constant for 48 h.   
Although Cl− easily precipitates Ag+, interference from Cl− was not 
observed in wet-ashed tissue solution.    Possibly, large amounts of  
NO3− contained in the wet-ashed solution may prevent the precipitation  
of AgCl.   However, when Cl−  was added to wet-ashed tissue solution,  
the signal of Ag(DDC)2+ decreased, but that of Pt(DDC)3+ remained  
constant.  
 
3.5 Accuracy, precision, limit of detection, limit of quantitation and linearity 
   In IAA extracted from 7M NaNO3 aqueous solution, the limit of  
detection and the limit of quantitation were 3 and 10 pg, since S/N = 3  
and 10, respectively ( Fig. 3(a)).   These concentrations corresponded 
to 6 and 20 pg Pt/mg wet weight, respectively, in tissues.  In the 
case of blank kidney tissue (Fig. 3(b)), blank tissues did not exhibit any  
peaks at m/z 639 and the limit of detection in tissue was 6 pg/mg wet  
weight in all tissues.   Intra-day and inter-day accuracy and precision of  
the method were examined and expressed as recovery and co-efficient of  
variation (C.V.) of the determination for Pt spiked at 20, 100, 200 and 2000  
pg/mg wet weight (Table 1).   The deviation from the nominal value and  
the C.V. were lower than10 % in all samples in both intra-day and inter-day  
variations at 200 and 2000 pg/mg wet weight, respectively.   Therefore,  
the values for inter-day variation at 200 and 2000 pg/mg wet weight were  
not listed.   The limit of quantitation was 20 pg/mg wet weight since the  
recoveries were in the range of 78 – 118 %, and the C.V. was less than 21 
%, respectively, at 20 pg/mg in both intra-day and inter-day variations.  
The integrated areas of mass spectra monitored at m/z of Pt(DDC)3+  
relative to the area of Ag(DDC)2+, (y in pg), were proportional to the  
amounts of Pt, (x in pg), in the concentration ranges studied.   
Specifically, the calibration equations calculated on 12 points (four  
concentrations such as 20, 100, 200 and 2000 pg/mg wet weight, three  
determinations per each concentration) were exceptional for all tissues 
(Table 2) . 
  
3.6 Patient samples 
    Fig. 2(b) demonstrates the mass spectrum of 1 μl of IAA extracted  
from 0.5 mg patient kidney tissue containing 500 pg Ag as IS.   Although  
the tissue contained several metals such as Fe and Cu reacting with DDC  
[7] at high concentrations, the peaks of Pt(DDC)3+ and Ag(DDC)2+ were  
not interfered with, e.g. the kidney.     This fact was also confirmed by  
the observation that metal ions such as Hg2+, W6+, Hf4+, Fe3+, Zn2+, Cu2+,  
Mn2+, Ti4+, V5+, Cr6+, Cd2+ and Zr4+ at 10−4 M, i.e., at approximately 10 ng,  
did not show peaks at the peaks of Pt(DDC)3+ and Ag(DDC)2+,  
respectively, under the same treatment.  
   The mass spectra of flow injections monitored at m/z 639 are shown  
in Fig. 3(b).   One μl of IAA extracted from 0.5 mg of the reference  
samples and patient samples were injected in duplicate.   These samples  
were those of blank kidney, the kidney standard spiked with Pt at 1000  
pg/mg wet weight and patient samples such as cerebrum, cerebellum,  
thymus, heart, adrenal, testis, pancreas, lung, spleen, left kidney, right  
kidney and liver, respectively, from left to right.  Pt levels in tissues  
obtained from the patient were calculated based on the kidney standard  
(Fig. 3(b)), and were listed as value 1 in Table 3.   Following 
measurement in triplicate for each tissue, patient Pt levels were also  
calculated based on the respective calibration curve in Table 2, and are  
listed as value 2 in Table 3.   In previous reports using healthy animals,  
the Pt level of the kidney was 10-fold greater than that of the liver after  
two hours [12] and 3-fold greater after 8 days [3], respectively.   The  
Pt level of the kidney was lower than that of the liver in our patient in the 
present study, whose death occurred 44 days after receiving an accidental  
overdose of cisplatin.   We believe that the duration of time may be one 
of the contributing factors, which affected the distribution of Pt.   
Conclusion 
   Herein, we propose a method for the rapid and decisive  
determination of platinum by ESI-MS.   Various metals in tissues did  
not interfere with the assay.   The method was employed for the  
quantitation of platinum in several tissues obtained from a patient with 
cancer who died 44 days after receiving accidental overdose of cisplatin. 
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Figure captions 
Figure 1. Mass spectra of 1 μl of IAA containing 1 ng Pt and 1 ng Ag  
were recorded from m/z 400 – 650 (a) and m/z 636 – 646 (b),  
respectively.  
 
Figure 2. (a): Mass spectrum of 1 μl of IAA containing 10 pg Pt and  
50 pg Ag.   (b): Mass spectrum of 1 μl of IAA, extracted from 0.5  
mg kidney tissue from the patient, containing 500 pg Ag as IS.   
 
Figure 3. (a): Mass spectra of flow injections monitored at m/z 639.  
One μl of IAA containing either 0, 3, 10 or 100 pg Pt was injected in 
triplicate for each amount, indicating that the limit of detection was 3 pg 
Pt per injection; (b): Mass spectra of flow injections monitored at m/z  
639.  One μl of IAA extracted from 0.5 mg of blank kidney, the  
kidney standard spiked with 1000 pg Pt/mg, and patient samples such  
as cerebrum, cerebellum, thymus, heart, adrenal gland, testis, pancreas,  
lung, spleen, left kidney, right kidney and liver, respectively, from left  
to right in duplicate.  
 Table 1    
Recovery and coefficient of variation of determination for Pt spiked at 20 to 2000 
pg/mg wet tissue.   Inter-day values spiked at 200 and 2000 pg, see the text.    
                   Intra-day (3 times)                     Inter-day (3 days)   
                       Recovery  %                      Recovery  % 
                        (C.V. %)                          (C.V. %)        
Pt spiked(pg)     20     100     200    2000               20     100     
cerebrum       115     116     103     100               87     103 
              (21.0)   (13.0)    (8.0)    (4.0)             (16.5)  (12.3) 
   
cerebellum      118     114      99      97              105     103     
              (20.5)    (7.9)    (4.5)    (7.1)             (13.5)   (6.0)   
thymus         97      95      94     105               84      94  
               (9.4)    (9.6)    (4.2)    (5.0)             (11.8)   (5.6)  
    
heart           107     100      98      97               87     102  
              (17.7)    (3.5)    (9.4)    (6.8)             (10.8)   (2.1)   
  
adrenal         115     113     102      97              109     100  
              (13.1)    (6.6)    (5.2)    (3.6)             (13.3)   (8.2)    
 
testis          114     102      99      95              109      95  
              (11.9)   (11.1)   (1.6)    (1.9)              (15.2)   (4.1)  
 
pancreas       103     106     100      98               99     101  
              (15.4)   (15.2)   (2.6)    (0.4)              (10.7)   (4.5)  
  
lung           78      81      98      97               94      93  
              (12.7)   (9.1)    (5.1)    (5.6)              (20.2)  (10.3)  
   
spleen          96      82     105      96              102      95   
               (7.1)   (10.3)    (4.8)    (3.8)              (14.4)   (10.3)  
 
kidney        103     108     104     100               87      98   
               (9.4)   (11.4)   (2.5)    (5.5)              (13.1)   (2.3)   
  
liver            83      86      95      99               91     102  
              (12.5)    (9.5)    (6.1)    (2.5)             (15.2)   (8.0)    
 
 Table 2    
Calibration curve and correlation coefficient for Pt spiked at 20 – 2000 pg/mg wet 
tissue.       
                  Calibration equation   S.D.    S.D. 
 Sample             y = a x + b          a      b    Correlation coefficient 
                    (y, x : pg)                 (pg) 
cerebrum          y = 0.988 x + 4.6     0.015    7.4          0.999    
cerebellum         y = 0.967 x + 4.2     0.028   14.0          0.996    
thymus            y = 1.053 x – 5.6     0.020   10.0          0.998    
heart              y = 0.969 x + 1.1     0.026   13.3          0.996    
adrenal            y = 0.966 x + 5.2     0.014    7.2          0.999    
testis              y = 0.952 x + 3.0     0.008    3.8          0.999    
pancreas           y = 0.983 x + 2.1     0.006    3.0          0.999    
lung               y = 0.974 x - 3.4      0.022   11.1          0.997    
spleen             y = 0.960 x + 0.5     0.016    7.8          0.998    
kidney             y = 0.997 x + 3.0     0.021   10.8          0.998   
liver               y = 0.993 x – 4.1     0.010    5.1          0.999    
  
 Table 3    
Pt level listed as “Value 1” was calculated based on the comparison between the peak in 
each tissue (n=2) and that in standard kidney shown in Fig. 3 (b), and that listed as 
“Value 2” was calculated from another peak in each tissue (n=3) using the respective 
calibration curve listed in table 2.       
 
 Sample               Value 1                   Value 2 
                  (pg/mg wet tissue)          (pg/mg wet tissue)   
cerebrum                50                     48 ± 8  
cerebellum               40                     36 ± 3 
thymus                  40                     60 ± 12 
heart                   300                    267 ± 19 
adrenal                 460                    365 ± 61 
testis                   700                    653 ± 41 
pancreas                460                    413 ± 57 
lung                    500                    487 ± 40 
spleen                  280                    290 ± 6 
kidney                1200                   1280 ± 118 
liver                   1600                   1680 ± 150 
  
 
 
 
